Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 5
2016 4
2017 1
2018 2
2019 7
2020 6
2021 5
2022 11
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Mutational landscape of inflammatory breast cancer.
Bertucci F, Lerebours F, Ceccarelli M, Guille A, Syed N, Finetti P, Adélaïde J, Van Laere S, Goncalves A, Viens P, Birnbaum D, Mamessier E, Callens C, Bedognetti D. Bertucci F, et al. Among authors: guille a. J Transl Med. 2024 Apr 18;22(1):374. doi: 10.1186/s12967-024-05198-4. J Transl Med. 2024. PMID: 38637846 Free PMC article.
Absence of chromosome axis protein recruitment prevents meiotic recombination chromosome-wide in the budding yeast Lachancea kluyveri.
Legrand S, Saifudeen A, Bordelet H, Vernerey J, Guille A, Bignaud A, Thierry A, Acquaviva L, Gaudin M, Sanchez A, Johnson D, Friedrich A, Schacherer J, Neale MJ, Borde V, Koszul R, Llorente B. Legrand S, et al. Among authors: guille a. Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2312820121. doi: 10.1073/pnas.2312820121. Epub 2024 Mar 13. Proc Natl Acad Sci U S A. 2024. PMID: 38478689
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon E, Lefeuvre-Plesse C, Martinez A, Chauleur C, Lortholary A, Favier L, Bats AS, Guille A, AdélaÏde J, Finetti P, de Casteljac V, Provansal M, Mamessier E, Bertucci F, Ray-Coquard I, Sabatier R. Nigon E, et al. Among authors: guille a. J Transl Med. 2023 Jun 23;21(1):408. doi: 10.1186/s12967-023-04264-7. J Transl Med. 2023. PMID: 37353806 Free PMC article.
Erythroleukemia: Classification.
Cervera N, Guille A, Adélaïde J, Hospital MA, Garciaz S, Mozziconacci MJ, Vey N, Gelsi-Boyer V, Birnbaum D. Cervera N, et al. Among authors: guille a. EJHaem. 2023 Mar 17;4(2):450-453. doi: 10.1002/jha2.676. eCollection 2023 May. EJHaem. 2023. PMID: 37206278 Free PMC article.
BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib.
Velazquez C, Orhan E, Tabet I, Fenou L, Orsetti B, Adélaïde J, Guille A, Thézénas S, Crapez E, Colombo PE, Chaffanet M, Birnbaum D, Sardet C, Jacot W, Theillet C. Velazquez C, et al. Among authors: guille a. Front Oncol. 2023 Mar 17;13:1125021. doi: 10.3389/fonc.2023.1125021. eCollection 2023. Front Oncol. 2023. PMID: 37007122 Free PMC article.
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Sabatier R, Garnier S, Guille A, Carbuccia N, Pakradouni J, Adelaide J, Provansal M, Cappiello M, Rousseau F, Chaffanet M, Birnbaum D, Mamessier E, Gonçalves A, Bertucci F. Sabatier R, et al. Among authors: guille a. Front Oncol. 2022 Jul 29;12:946257. doi: 10.3389/fonc.2022.946257. eCollection 2022. Front Oncol. 2022. PMID: 35965534 Free PMC article.
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A, Salas S, Bertucci F, Sobinoff AP, Adélaïde J, Guille A, Finetti P, Noble JR, Churikov D, Chaffanet M, Lavit E, Pickett HA, Bouvier C, Birnbaum D, Reddel RR, Géli V. de Nonneville A, et al. Among authors: guille a. EMBO Mol Med. 2022 Oct 10;14(10):e15859. doi: 10.15252/emmm.202215859. Epub 2022 Aug 3. EMBO Mol Med. 2022. PMID: 35920001 Free PMC article.
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.
Neron M, Guille A, Allegre L, Colombo PE, Leaha C, Adelaide J, Carbuccia N, Courtier F, Boissiere F, Crapez E, Fabbro M, Gouy S, Mamessier E, Lambaudie É, Birnbaum D, Bertucci F, Chaffanet M. Neron M, et al. Among authors: guille a. J Pers Med. 2022 Apr 19;12(5):655. doi: 10.3390/jpm12050655. J Pers Med. 2022. PMID: 35629078 Free PMC article.
48 results